ITPKA and inflammatory bowel disease: Based on integrating IBD GWAS with eQTLs from 203 anti-tumour necrosis factor-resistant CD patients, a previous study found that polymorphism rs28374715 was associated with decreased risk of IBD through downregulated ITPKA in blood and intestine.34